Covestor

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
2,847
Total Value
146983
Accession Number
0001909846-25-000002
Form Type
13F-HR
Manager Name
Covestor
Data Enrichment
93% identified
2,661 identified186 unidentified

Holdings

2,847 positions • $147.0K total value
Manager:
Search and click to pin securities to the top
VSE CORP
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
RPC INC
Shares:73
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
SOUNDTHINKING, INC.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
STEWART INFORMATION SERVICES CORP
Shares:2
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
StepStone Group Inc.
Shares:3
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
4D Molecular Therapeutics, Inc.
Shares:17
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
89bio, Inc.
Shares:12
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Allogene Therapeutics, Inc.
Shares:39
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
ANAPTYSBIO, INC
Shares:6
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Apogee Therapeutics, Inc.
Shares:3
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
SOUTH PLAINS FINANCIAL, INC.
Shares:11
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Star Holdings
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
ArriVent BioPharma, Inc.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
STANDEX INTERNATIONAL CORP/DE/
Shares:2
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Celldex Therapeutics, Inc.
Shares:9
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
CG Oncology, Inc.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Cogent Biosciences, Inc.
Shares:11
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Cullinan Therapeutics, Inc.
Shares:5
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Day One Biopharmaceuticals, Inc.
Shares:29
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Disc Medicine, Inc.
Shares:2
Value:$0
% of Portfolio:0.0% ($0/$147.0K)